Alzheimer’s disease is the most common form of age related dementia, affecting as many as 5.3 million Americans and accounting for up to 80% of dementia cases. A progressive brain disease, Alzheimer’s disease targets parts of the brain destroying brain cells, causing memory loss, and creating problems with thinking and behavior.
Early stages of Alzheimer’s often manifests in forgetting recent events or conversations. As the disease progresses, sufferers develop severe memory impairment and lose the ability to carry out regular everyday tasks. Although there is no cure, current treatments combine medication with supportive services can help stabilize and even improve life for Alzheimer’s disease sufferers.
We at Artemis Institute for Clinical Research conduct clinical trials for investigative medications for the treatment of Alzheimer's disease. Qualified research participants will receive financial compensation for their time and travel, study related medical and psychological evaluations by our doctors, and the investigative study medication at no cost. Help advance medicine and medical research through clinical trial participation!